NS · Healthcare

Sakar Healthcare Ltd (SAKAR)

Pharmaceuticals & Biotechnology

Sakar Healthcare Ltd (SAKAR) is listed on NS in the Healthcare sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $18.24B, P/E ratio is 59.85, net margin is 9.8%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for SAKAR

Market cap

$18.24B

P/E ratio

59.85

Net margin

9.8%

Sakar Healthcare Ltd (SAKAR) — FAQ

What is Sakar Healthcare Ltd's market cap?

Sakar Healthcare Ltd (SAKAR) has a reported market cap of $18.24B (data as of 2026-07-10).

What is SAKAR's P/E ratio?

The price-to-earnings (P/E) ratio for Sakar Healthcare Ltd (SAKAR) is 59.85 (data as of 2026-07-10).

Does Sakar Healthcare Ltd pay a dividend?

Dividend yield is not available in the current snapshot for Sakar Healthcare Ltd (SAKAR). Check the MyAverix Finance app for the latest dividend data.

What sector is Sakar Healthcare Ltd in?

Sakar Healthcare Ltd (SAKAR) is classified in the Healthcare sector (Pharmaceuticals & Biotechnology industry).

What exchange is SAKAR listed on?

SAKAR is listed on NS.

What is Sakar Healthcare Ltd's net margin?

Sakar Healthcare Ltd (SAKAR) reports a net margin of 9.8% (data as of 2026-07-10).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

09R (09R) 10X GENOMICS DL -00001 (1KJ) 160 Health International Ltd (2656) 1CM INC. (IQ70) 2cureX AB (2CUREX) 3-D Matrix Ltd (DMTRF) 3D Global Biotech Inc. (6808) 3D Medicines Inc (1244)